Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis.
BACKGROUND
Cardiac sarcoidosis (CS) occurs in up to 25% of patients with pulmonary involvement. Early diagnosis is critical because sudden death from ventricular arrhythmias can be the initial presentation. We sought to evaluate the diagnostic utility of signal-averaged ECG (SAECG) for detection of cardiac involvement of sarcoidosis.


METHODS
Subjects with biopsy proven sarcoidosis and symptoms suggestive of possible cardiac involvement were included in the cohort. Standard criteria for SAECG were used. Subjects were considered to have CS if they met criteria established by the Japanese Ministry of Health and Welfare modified to include cardiac MRI.


RESULTS
Of the 88 patients in the cohort 27 had evidence of CS independent of the SAECG results. The SAECG was abnormal in 14 of these 27 patients and 11 of the 61 of the subjects without cardiac involvement (P < 0.01). The sensitivity of SAECG detection of CS was 52% with a specificity of 82%. For the entire cohort, SAECG had a positive predictive value (PPV) of 0.56 and a negative predictive value (NPV) of 0.79. Within a subgroup of 67 patients with an unfiltered QRS duration of <100 ms, the specificity for diagnosing cardiac sarcoidosis improves to 100% with a reduced sensitivity of 36.8. Of the SAECG parameters, LAS40 was significantly associated with the diagnosis of cardiac sarcoidosis for the entire cohort (P < 0.01) and among the subgroup of patients with an unfiltered QRS duration of <100 ms (P < 0.01).


CONCLUSIONS
SAECG is a useful screening tool in the evaluation of sarcoidosis for detection of cardiac involvement.
Section of Cardiac Electrophysiology, University of Colorado, and Division of Cardiology, National Jewish Health, Denver, CO, USA.
Joseph L
JL
Schuller
Christopher M
CM
Lowery
Matthew
M
Zipse
Ryan G
RG
Aleong
Paul D
PD
Varosy
Howard D
HD
Weinberger
William H
WH
Sauer
D000328:Adult; D000368:Aged; D009202:Cardiomyopathies / Q000175:diagnosis*; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology; D006331:Heart Diseases / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D017565:Sarcoidosis, Pulmonary / Q000150:complications; D012680:Sensitivity and Specificity; D017180:Tachycardia, Ventricular / Q000175:diagnosis
Arch Pathol Lab Med. 1995 Feb;119(2):167-72
7848065
Medicine (Baltimore). 2004 Nov;83(6):315-334
15525844
Am J Cardiol. 2000 Mar 1;85(5):618-23
11078277
Circulation. 1993 Apr;87(4):1083-92
8462136
Ann Noninvasive Electrocardiol. 2003 Apr;8(2):112-20
12848791
J Cardiovasc Electrophysiol. 2009 May;20(5):578-83
19175448
Am J Med. 1977 Jul;63(1):86-108
327806
Circulation. 2008 May 27;117(21):e350-408
18483207
Circulation. 2006 May 23;113(20):e771-3
16717157
J Am Coll Cardiol. 2005 May 17;45(10):1683-90
15893188
Am J Cardiol. 2009 Aug 15;104(4):571-7
19660614
Eur Heart J. 2005 Apr;26(8):755-61
15673543
Circulation. 1978 Dec;58(6):1204-11
709777
Circulation. 2008 Sep 30;118(14):1497-1518
18833586
J Am Coll Cardiol. 1991 Oct;18(4):937-43
1894867